West Pharmaceutical Services Inc (WST) investors sentiment increased to 1.34 in Q3 2018. It’s up 0.39, from 0.95 in 2018Q2. The ratio is positive, as 141 hedge funds opened new or increased holdings, while 105 decreased and sold equity positions in West Pharmaceutical Services Inc. The hedge funds in our database now hold: 65.51 million shares, down from 71.57 million shares in 2018Q2. Also, the number of hedge funds holding West Pharmaceutical Services Inc in top ten holdings decreased from 2 to 1 for a decrease of 1. Sold All: 22 Reduced: 83 Increased: 84 New Position: 57.

The stock of Huami Corporation (NYSE:HMI) is a huge mover today! The stock increased 5.14% or $0.61 during the last trading session, reaching $12.59. About 338,997 shares traded or 270.34% up from the average. Huami Corporation (NYSE:HMI) has 0.00% since February 4, 2018 and is . It has by 0.00% the S&P500. Some Historical HMI News: 21/05/2018 – Huami Sees 2Q Rev CNY650M-CNY675; 28/03/2018 – SHANGHAI HUAMI-A HALTS TRADING IN SHENZHEN: 300462 CH; 09/04/2018 – Huami Announces Global Availability of The Amazfit Stratos Premium Multisport GPS Smartwatch; 21/05/2018 – Huami 1Q EPS 1c; 27/04/2018 – Huami Corporation Files 2017 Annual Report on Form 20-F; 21/05/2018 – Huami 1Q Rev $93.4M; 26/03/2018 Huami 4Q Rev $115.7M; 26/03/2018 – Huami 4Q EPS 5c; 31/05/2018 – Huami Corporation Announces Official Launch of Mi Band 3; 27/04/2018 – Huami Corp Files 2017 Annual Report on Form 20-FThe move comes after 5 months positive chart setup for the $756.96 million company. It was reported on Feb, 4 by . We have $13.22 PT which if reached, will make NYSE:HMI worth $37.85 million more.

More notable recent Huami Corporation (NYSE:HMI) news were published by: Investingnews.com which released: “Huami Becomes McLaren’s eSports Wearables Partner | INN – Investing News Network” on January 16, 2019, also Seekingalpha.com with their article: “Huami: Overlooked And Misunderstood – Seeking Alpha” published on October 15, 2018, Seekingalpha.com published: “Huami Could Face Headwinds When IPO Lockup Expires – Seeking Alpha” on July 30, 2018. More interesting news about Huami Corporation (NYSE:HMI) were released by: Seekingalpha.com and their article: “Huami Corporation 2018 Q3 – Results – Earnings Call Slides – Seeking Alpha” published on November 26, 2018 as well as Seekingalpha.com‘s news article titled: “Huami Corporation (HMI) CEO Wang Huang on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: August 20, 2018.

Huami Corporation develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. The company has market cap of $756.96 million. It offers smart bands, watches, scales, and related accessories under the Xiaomi brand names. It has a 18.19 P/E ratio.

West Pharmaceutical Services, Inc. manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company has market cap of $7.76 billion. The companyÂ’s Proprietary Products segment offers stoppers and seals for injectable packaging systems; and syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. It has a 51.17 P/E ratio. It also provides drug containment solutions, including CZ vials, syringes, and cartridges; and self-injection systems, as well as specialized testing services for drug packaging, devices, and administration systems.

Analysts await West Pharmaceutical Services, Inc. (NYSE:WST) to report earnings on February, 21. They expect $0.72 earnings per share, up 12.50% or $0.08 from last year’s $0.64 per share. WST’s profit will be $53.34M for 36.37 P/E if the $0.72 EPS becomes a reality. After $0.76 actual earnings per share reported by West Pharmaceutical Services, Inc. for the previous quarter, Wall Street now forecasts -5.26% negative EPS growth.

More news for West Pharmaceutical Services, Inc. (NYSE:WST) were recently published by: Seekingalpha.com, which released: “West Pharma recalls certain IV transfer devices – Seeking Alpha” on February 02, 2019. Seekingalpha.com‘s article titled: “Dividend Champion Spotlight: West Pharmaceutical Services – Seeking Alpha” and published on November 17, 2018 is yet another important article.

The stock increased 1.48% or $1.53 during the last trading session, reaching $104.75. About 223,052 shares traded. West Pharmaceutical Services, Inc. (WST) has risen 8.04% since February 4, 2018 and is uptrending. It has outperformed by 8.04% the S&P500. Some Historical WST News: 26/04/2018 – West Pharma Sees FY Adj EPS $2.80-Adj EPS $2.90; 15/03/2018 – GAMIDA CELL APPOINTS SHAI LANKRY AS CHIEF FINANCIAL OFFICER; 26/04/2018 – West Pharma 1Q Net $43.6M; 26/04/2018 – WEST PHARMACEUTICAL SERVICES INC WST.N FY2018 SHR VIEW $2.82, REV VIEW $1.72 BLN — THOMSON REUTERS l/B/E/S; 09/05/2018 – USS Investment LTD. Buys New 1.2% Position in West Pharma; 30/05/2018 – West Pharma Closes Above 200-Day Moving Average: Technicals; 07/03/2018 HEALTHPRIZE & WEST EXTEND CONNECTED HEALTH PARTNERSHIP; 20/04/2018 – DJ West Pharmaceutical Services Inc, Inst Holders, 1Q 2018 (WST); 03/05/2018 – West Pharma Board Approves 4Q Dividend Increase to 15c; 26/04/2018 – West Pharma Sees FY Sales $1.72B-$1.73B